课题基金 / 基金详情

项目摘要

项目成果

STUART A. KAUFFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal aims at the development of mathematical, computer, recombinant DNA, selection and screening procedures to attain adaptive evolution of entirely novel peptides or fusion proteins with useful catalytic, ligand binding, structural or other features. Potential uses range from industrial catalysis to production of new drugs and vaccines. We have at present generated about 10,000,000,000 novel genes cloned into lambda- gtll, and appear to have successfully identified novel fusion peptides conferring gentamycin resistance to host bacteria. Mathematical work includes development of theory about the character of "adaptive walks" in the space of possible peptides, via point mutations or recombination, to peptides which are local or global optima for a desired function. We shall complete current work characterizing different novel peptides which as fusion proteins confer resistance to gentamycin in E. Coli lysogens. We will then test the relative efficiency of point mutants versus recombination in adaptive hill climbing. In addition we shall select for novel peptides or fusion proteins with a desired catalytic function. Notably we will select for beta- galactosidase function, and triosephosphate isomerase function in appropriate bacterial deletion mutants. A broad purpose of our efforts is to obtain novel peptides which can mimic the biological effects of almost arbitrary signal molecules such as hormones, growth factors, even pathogenic antigens. The central idea is simple: screen or select for novel peptides which are bound by a shape complement of the target molecule. The shape complement might be a receptor for a growth factor, or an antibody against the growth factor. As an initial example, we shall screen for epidermal growth factor (EGF) mimetic peptides which cross react to antibodies against the EGF target molecule. In addition we shall develop a general procedure to select for novel peptides mimicing arbitrary epitopes. Such mimetic peptides may be useful as drugs or vaccines. The fundamental importance of this work includes analysis of the distribution of function in peptide space and opening the way towards a technology of applied molecular evolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRINCIPLES OF ADAPTATION IN COMPLEX SYSTEMS
  • 批准号:
    2187142
  • 项目类别:
  • 资助金额:
    $14.4万
  • 财政年份:
    1993
  • 负责人:
    STUART A. KAUFFMAN
  • 依托单位:
PRINCIPLES OF ADAPTATION IN COMPLEX SYSTEMS
  • 批准号:
    3308790
  • 项目类别:
  • 资助金额:
    $15.6万
  • 财政年份:
    1993
  • 负责人:
    STUART A. KAUFFMAN
  • 依托单位:
PRINCIPLES OF ADAPTATION IN COMPLEX SYSTEMS
  • 批准号:
    2518996
  • 项目类别:
  • 资助金额:
    $8.4万
  • 财政年份:
    1993
  • 负责人:
    STUART A. KAUFFMAN
  • 依托单位:
PRINCIPLES OF ADAPTATION IN COMPLEX SYSTEMS
  • 批准号:
    2187143
  • 项目类别:
  • 资助金额:
    $14.96万
  • 财政年份:
    1993
  • 负责人:
    STUART A. KAUFFMAN
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: